RaiaDrogasil Sustainability Profile
RaiaDrogasil, a leading player in the Brazilian pharmaceutical retail sector, is headquartered in São Paulo, Brazil. Founded in 2011 through the merger of two prominent pharmacy chains, Raia and Drogasil, the company has rapidly expanded its footprint across major urban regions in Brazil, establishing itself as a trusted name in healthcare. Specialising in the sale of prescription medications, over-the-counter drugs, and health and beauty products, RaiaDrogasil distinguishes itself with a commitment to customer service and accessibility. The company operates a vast network of stores, ensuring that quality healthcare products are readily available to the public. With a strong market position, RaiaDrogasil has achieved significant milestones, including numerous awards for excellence in retail and customer satisfaction. Its dedication to innovation and community health initiatives further solidifies its reputation as a leader in the industry.
DitchCarbon Score
How does RaiaDrogasil's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
RaiaDrogasil's score of 33 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
RaiaDrogasil's reported carbon emissions
In 2023, RaiaDrogasil reported total carbon emissions of approximately 586,770,430 kg CO2e, with Scope 2 emissions accounting for about 3,838,630 kg CO2e. This represents a slight decrease from 2022, where total emissions were approximately 587,278,420 kg CO2e, with Scope 2 emissions at about 5,020,200 kg CO2e. The company has not disclosed any Scope 1 emissions data for the years reported, and there is no available data for Scope 3 emissions in 2023. However, in 2020, RaiaDrogasil reported Scope 1 emissions of approximately 27,833,480 kg CO2e, Scope 2 emissions of about 11,777,370 kg CO2e, and Scope 3 emissions of approximately 1,248,850 kg CO2e. Despite the fluctuations in emissions, RaiaDrogasil has not set specific reduction targets or initiatives as part of their climate commitments, nor have they participated in the Science Based Targets initiative (SBTi). The company’s emissions data is not cascaded from any parent organization, indicating that all reported figures are directly from RaiaDrogasil S.A. Overall, while RaiaDrogasil has made strides in tracking its emissions, further commitments and reduction strategies would enhance its climate action profile.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 27,833,480 | - | - | - |
| Scope 2 | 11,777,370 | 00,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 1,248,850 | - | - | - |
How Carbon Intensive is RaiaDrogasil's Industry?
How Carbon Intensive is RaiaDrogasil's Location?
RaiaDrogasil's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
RaiaDrogasil has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
